aboutconf

Time	Day 1 Sunday Feb. 8, 2004	Day 2 Monday Feb. 9, 2004		Day 3 Tuesday Feb. 10, 2004		Day 4 Wednesday Feb. 11, 2004		Thursday Feb. 12, 2004
8:30- 9 am	9 am-12 noon Hands-On Computer Workshop HIV Sequence, Immunology and Vaccine Databases (This workshop can accommodate 50 participants; there is no additional fee, however, due to limited space, preregistration is required.) 9 am-3 pm Program Committee Workshop for New Investigators and Trainers (domestic & international) 3-5 pm Symposium Developments in the Global Response to AIDS	Plenary Molecular Virology and Pathogenesis of Hepatitis C Charles Rice Rockefeller Univ, New York, NY, USA		Plenary HLA Imprinting: Implications for Selection of Vaccine Immunogens Simon Mallal Ctr for Clin Immunology and Biomed Statistics, Royal Perth Hosp, Australia		Plenary HIV Vaccine Efficacy Trials: Lessons Learned and Future Directions Susan Buchbinder San Francisco Dept of Publ Hlth, CA, USA		8.30-11 am Post-Conference Workshop Pharmacological Monitoring of Complex Patient Treatment Scenarios (This workshop can accommodate 350 participants and is open to Retrovirus Conference registrants only. There is no additional fee, however, due to limited space, preregistration is required.) post-conference activities including: affiliated events + investigator meetings + working group meetings
9- 9:30 am		Plenary How Close Are We to an Effective Microbicide? Robin Shattock St George’s Hosp Med Sch, London, UK		Plenary DNA Editing and Host Resistance Factors Michael Neuberger Med Res Council, Cambridge, UK		Plenary TB/HIV: Is there a Scientific Basis for Hope? Peter M. Small Bill & Melinda Gates Fndn, Seattle, WA, USA and Stanford Univ Med Ctr, CA, USA
9:30- 10 am		Break		Break		Break
10 am- 12:30 pm		Oral Abstract Sessions Immune Responses to HIV Acute/Recent Infection Neuropathogenic Manifestations of HIV Infection (includes 1 Minilecture: Peripheral Neuropathy Associated with HIV and ARV: Update on Diagnosis and Management) Transmission, Selection, and Persistence of Drug Resistant Virus (includes 1 Minilecture: Maternal and Infant Treatment Strategies for Preventing MTCT)		Oral Abstract Sessions Viral Genes and Cellular Co-Factors Complications of HIV Infection and Antiretroviral Therapy Epidemiology of HIV Infection in the US (includes 2 Minilectures: HIV/AIDS in Jails and Prisons and Men on the "Down Low": More Questions Than Answers) Maternal-to-Child Transmission		Oral Abstract Sessions Retroviral Pathogenesis Pharmacology and New Antiretroviral Agents Global AIDS: Epidemiology, Virology, and Clinical Aspects (includes 2 Minilectures: Herpes Simplex and the Global Epidemiology of HIV and Interaction of HIV and Malaria) HIV Infection in Women and Children Preventive Microbicide Strategies
12:30-1:30 pm		Lunch		Lunch		Lunch
1:30- 2:30 pm		Poster Sessions		Poster Sessions		Poster Sessions
2:30- 3:30 pm			Poster Discussion Group Trans- mission of Drug Resistance HIV: Conflicting Trends and Clinical Significance	1-4 pm Hands-On Computer Workshop HIV Sequence, Immunology and Vaccine Databases (limited space; preregistration is required)	Poster Discussion Group New Insights into Intracellular and Plasma Pharma-cokinetics of Antiretro-virals		Poster Discussion Group HPV Infection and Anal Cancer
3:30- 4 pm		Break		Break		Break
4-6 pm	5:30-7 pm Opening Session Bernard Fields Memorial Lecture: Cellular Factors and HIV Budding Wesley Sundquist Eccles Inst of Human Genetics, Univ of Utah, Salt Lake City, USA Keynote Lecture Ambassador Stephen H. Lewis United Nations Special Envoy for HIV/AIDS in Africa	Symposium Virus-Host Cell Synapses Symposium Emerging Long Term Complications of HIV and its Therapies in Children, Adolescents and Women Oral Abstract Session Antiretroviral Therapy: Emergence, Mechanisms, and Persistence of Resistance		Symposium Host Restriction Factors Symposium HIV Vaccines: Clinical Trial Results Call for More Basic Science Oral Abstract Session HIV/HCV Co-Infection		Symposium Advances in the Science of Antiretroviral Therapy: Drug Discovery to Global Strategy Oral Abstract Session Clinical and Preclinical Vaccine Studies
7-9 pm	Welcome Reception


Time	Monday Feb. 9, 2004	Tuesday Feb. 10, 2004	Wednesday Feb. 11, 2004
8 am-6 pm	Poster Hall Open All posters will be available for viewing for the duration of the conference.
1:30- 3:30 pm	Poster Sessions T-Cell Responses in Adults T-Cell Responses in Children HLA and Immunity Cellular Responses under HAART Viral Envelopes: Structure-Function Studies Virus Entry, Receptors, and Co-Receptors Viral Replication: Uncoating, RT, and Integration Viral Replication: Post-Integration Events Antiretroviral Therapy: Predictors of Response and Virologic Failure Antiretroviral Treatment Strategies Transmission of Drug Resistant HIV-1: Conflicting Trends and Clinical Significance Prevalence of Drug Resistance: Cohort Studies Impact of Virus Type/Subtype on Resistance Development Drug Resistance Testing: New Methods, Interpretations, and Reproducibility Pathogenetic Mechanisms of Abnormalities of Glucose, Insulin, Lipid, and Mitochondrial Metabolism Dyslipidemias and Body Fat Abnormalities: Incidence, Risk Factors, Response to Therapy Bone Metabolism Abnormalities Systemic and Organ Complications of HIV-1 and Antiretroviral Therapies Incidence of HIV-1 Infection Access to Care and Antiretroviral Therapy Descriptive Epidemiology and Testing Morbidity and Mortality of HIV-1 Infection In Vitro Microbicide Testing Clinical Interventions Antiretroviral Therapy in Pregnant Women Antiretroviral Therapy in Children Natural History of HIV-1 and Antiretroviral Treatment Response in Women HIV Expression in the Female Genital Tract	Poster Sessions Lymphocyte Immunophenotyping in SIV Infection Natural Killer Cell Subsets Cytokine Studies Dendritic Cells Correlates of Resistance to Infection Primary Infection: Viral Pathogenesis Primary Infection: Cellular Immunity Primary Infection: Treatment Trials and STIs Host Genetic Factors Viral Tropism and Coreceptor Use Viral Targets and Reservoirs Virus Neutralization Viral Replication: Cytokine Effects Neuropathogenesis: Animal Models and Mechanisms of Neuro Invasion Neuropathogenesis: Therapy and Clinical/Pre-Clinical Studies Neuropathogenesis: Clinical Correlates and Observational Studies General and Virus-Specific Immune Augmentation Strategies New Insights into Intracellular and Plasma Pharmacokinetics of Antiretrovirals Pharmacology of Reverse Transcriptase Inhibitors Pharmacology of Protease Inhibitors Activity of Drugs against Resistant Viruses Mechanisms of Drug Resistance and Increased Susceptibility Interplay between STI's and Drug Resistance Resistance Predictors of Virologic Response and Clinical Outcome Cardiovascular Complications: Pathogenesis Cardiovascular Complications: Risk Factors, Incidence, Prevalence, and Outcomes Atypical Mycobacterial and Tuberculous Opportunistic Infections Non-Mycobacterial Opportunistic Infections Epidemiology and Natural History of HIV-HCV Co-Infection Risk Behavior Parenteral Transmission of HIV-1 Infection Mother-to-Child Transmission Viral Pathogenesis in Mothers and Children Viral Load Monitoring Simplified CD4 Monitoring Antibody Detection Immunologic Monitoring	Poster Sessions Designing Vaccine Immunogens Vaccine Immunogenicity Immune Responses in SIV/SHIV Infections Vaccine Clinical Trials Viral Replication: Positive and Negative Host Co-Factors Viral Replication: Virus-Cell Interactions Viral Lineages and Evolution Mechanisms of Lymphocyte Dysfunction Viral Recombination and Superinfection Plasma Viremia Neuropathogenesis: Viral Co-Factors Neuropathogenesis: Host Co-Factors New Antiretroviral Agents: RTI's and PI's New Antiretroviral Agents: Entry Inhibitors New Antiretroviral Agents: Novel Approaches HIV in Resource Limited Settings: Clinical Manifestations and Testing Strategies Antiretroviral Agents in Resource Limited Settings Impact of Drug Resistance on Viral Fitness Evolution of Drug Resistance Pathogenesis and Persistence of Drug Resistance Emergence of Resistance to Specific Drugs and Drug Combinations HPV Infection and Anal Cancer Opportunistic Malignancies: Kaposi's Sarcoma and Lymphomas HCV Pathogenesis Therapy of HCV in HIV Co-Infected Individuals HIV-HCV Co-Infection: Organ Transplantation and Malignancy HAV and HBV: Prevention and Treatment Issues in HIV Infected Persons Molecular Epidemiology of HIV-1 Infection Pregnant Women and Children: Immunology Treatment in Pregnant Women and Children: Pharmacokinetics Treatment in Pregnant Women and Children: Toxicity Treatment in Pregnant Women and Children: Treatment Interruptions
2:30- 3:30 pm	Poster Discussion Group Transmission of Drug Resistant HIV-1: Conflicting Trends and Clinical Significance	Poster Discussion Group New Insights into Intracellular and Plasma Pharmacokinetics of Antiretrovirals	Poster Discussion Group HPV Infection and Anal Cancer